ROPHARMA SA financials
ROPHARMA SA
Country: RO Reporting currency: RON Latest annual report: 2021-12-31
LEI:
2138004ATSD4SVFAZ789 Financial statements
(RON, as reported — unscaled; 118 line items across 2 annual periods)
| Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Revenue | RON 776.7M | RON 716.3M |
| Other income | RON 113.6M | RON 94.6M |
| Operating expenses | RON 871.6M | RON 798.7M |
| Employee benefits expense | RON 108.0M | RON 96.0M |
| Operating profit (EBIT) | RON 18.7M | RON 12.2M |
| Net finance income / (cost) | -RON 5.1M | -RON 5.6M |
| Finance costs | RON 6.5M | RON 6.3M |
| Profit before tax | RON 13.5M | RON 6.6M |
| Profit for the year | RON 10.7M | RON 6.8M |
| — attributable to owners | RON 10.7M | RON 6.8M |
| — attributable to NCI | RON 842.2K | -RON 2.1M |
| Total comprehensive income | RON 15.4M | RON 15.3M |
| Cash flow statement | ||
| Cash generated from operations | RON 1.4M | -RON 8.8M |
| Net cash from operating activities | -RON 1.2M | -RON 10.2M |
| Net cash from investing activities | -RON 12.3M | -RON 16.1M |
| Purchase of PP&E (capex) | RON 17.2M | RON 11.9M |
| Purchase of intangibles | RON 1.4M | RON 2.4M |
| Net cash from financing activities | -RON 24.5M | -RON 10.5M |
| Lease liability payments | RON 10.4M | RON 9.6M |
| Net change in cash | -RON 38.0M | -RON 36.8M |
| Balance sheet | ||
| Total assets | RON 667.3M | RON 651.2M |
| Non-current assets | RON 302.2M | RON 291.5M |
| Property, plant & equipment | RON 187.8M | RON 185.2M |
| Right-of-use assets | RON 57.1M | RON 50.1M |
| Intangible assets & goodwill | RON 11.2M | RON 11.6M |
| Current assets | RON 365.1M | RON 359.7M |
| Cash & equivalents | RON 10.7M | RON 14.7M |
| Total equity | RON 219.6M | RON 201.9M |
| Non-controlling interests | RON 7.1M | RON 4.0M |
| Non-current liabilities | RON 87.8M | RON 90.9M |
| Long-term borrowings | RON 27.3M | RON 35.7M |
| Lease liabilities (non-current) | RON 52.5M | RON 46.4M |
| Current liabilities | RON 359.9M | RON 358.4M |
| Current portion of long-term borrowings | RON 13.5M | RON 15.3M |
| Lease liabilities (current) | RON 9.5M | RON 8.7M |
| Deferred tax liabilities | RON 8.0M | RON 8.8M |
| Derived metrics | ||
| Free cash flow | -RON 18.4M | -RON 22.1M |
| Operating margin | 2.4% | 1.7% |
| Net margin | 1.4% | 0.9% |
| Return on equity | 4.9% | 3.3% |
| Cash conversion ratio | -0.11× | -1.51× |
| Capex coverage | -0.07× | -0.85× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -RON 15.5M | RON 12.1M |
| Adjustments For Decrease Increase In Other Assets | RON 10.0M | RON 0 |
| Adjustments For Decrease Increase In Trade and Other Receivables | -RON 4.2M | RON 13.4M |
| Adjustments For Deferred Tax Expense | -RON 2.4M | -RON 54.8K |
| Adjustments For Depreciation and Amortisation Expense | RON 23.2M | RON 22.7M |
| Adjustments For Finance Income Cost | RON 508.7K | RON 637.7K |
| Adjustments For Gain Loss On Disposal of Investments In Subsidiaries Joint Ventures and Associates | RON 1.5M | — |
| Adjustments For Gains Losses On Fair Value Adjustment Investment Property | -RON 595.7K | -RON 1.6M |
| Adjustments For Impairment Loss Recognised In Profit Or Loss Goodwill | RON 446.1K | RON 0 |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | RON 3.0K | -RON 124.1K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | RON 333.9K | RON 3.7M |
| Adjustments For Increase Decrease In Trade and Other Payables | -RON 25.1M | -RON 72.0M |
| Adjustments For Interest Expense | RON 6.5M | RON 6.3M |
| Adjustments For Interest Income | RON 1.4M | RON 460.4K |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -RON 945.9K | -RON 29.6K |
| Bank Overdrafts Classified As Cash Equivalents | RON 34.0M | RON 39.9M |
| Capital Reserve | RON 66.2M | RON 56.2M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | -RON 23.3M | -RON 25.2M |
| Cash Flows From Used In Operations Before Changes In Working Capital | RON 36.3M | RON 37.7M |
| Changes In Inventories of Finished Goods and Work In Progress | RON 385.6K | -RON 93.2K |
| Changes In Other Provisions | RON 587.5K | -RON 757.1K |
| Comprehensive Income Attributable To Noncontrolling Interests | RON 842.2K | -RON 2.1M |
| Comprehensive Income Attributable To Owners of Parent | RON 14.6M | RON 17.4M |
| Comprehensive Income From Continuing Operations Attributable To Noncontrolling Interests | RON 0 | RON 0 |
| Cost of Merchandise Sold | RON 682.8M | RON 621.8M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | RON 0 | RON 10.0M |
| Current Government Grants | RON 249.6K | RON 266.6K |
| Current Payables On Social Security and Taxes Other Than Income Tax | RON 4.3M | RON 4.2M |
| Current Provisions | RON 310.0K | RON 904.2K |
| Current Tax Liabilities Current | RON 541.5K | RON 3.5K |
| Deferred Tax Expense Income Recognised In Profit Or Loss | RON 1.5M | RON 54.8K |
| Deferred Tax Relating To Items Charged Or Credited Directly To Equity | -RON 892.8K | -RON 1.6M |
| Depreciation Expense | RON 23.2M | RON 22.7M |
| Equity and Liabilities | RON 667.3M | RON 651.2M |
| Finance Income | RON 1.4M | RON 674.6K |
| Gains On Disposals of Noncurrent Assets | RON 945.9K | RON 29.6K |
| Goodwill Recognised As of Acquisition Date | RON 12.7M | RON 12.7M |
| Impairment Loss Recognised In Profit Or Loss Property Plant and Equipment | RON 591.8K | RON 0 |
| Impairment Loss Recognised In Profit Or Loss Trade Receivables | RON 111.6K | RON 4.2M |
| Income Tax Relating To Components of Other Comprehensive Income | RON 892.8K | RON 1.6M |
| Income Taxes Paid Refund Classified As Operating Activities | RON 2.6M | RON 1.3M |
| Increase Decrease Through Transfer Between Revaluation Reserve and Retained Earnings | RON 0 | RON 0 |
| Increase Decrease Through Transfer To Statutory Reserve | RON 0 | RON 0 |
| Increase Decrease Through Transfers and Other Changes Equity | RON 0 | RON 0 |
| Increase Decrease Through Treasury Share Transactions | RON 0 | RON 0 |
| Intangible Assets Other Than Goodwill | RON 22.7M | RON 21.6M |
| Interest Paid Classified As Operating Activities | RON 3.2M | RON 3.3M |
| Interest Received Classified As Operating Activities | RON 16.4K | RON 131.7K |
| Inventories Total | RON 130.2M | RON 114.7M |
| Investment Property | RON 10.8M | RON 10.1M |
| Issued Capital | RON 68.7M | RON 68.7M |
| Liabilities | RON 447.7M | RON 449.3M |
| Miscellaneous Other Operating Expense | RON 25.2M | RON 26.6M |
| Other Cash Payments To Acquire Interests In Joint Ventures Classified As Investing Activities | RON 947.5K | RON 2.6M |
| Other Comprehensive Income | RON 4.7M | RON 8.6M |
| Other Comprehensive Income Net of Tax Gains Losses On Revaluation | RON 5.6M | RON 10.2M |
| Other Expense By Function | RON 32.9M | RON 26.8M |
| Other Gains Losses | — | -RON 80.1K |
| Other Noncurrent Financial Assets | RON 1.0K | RON 146.7K |
| Prepayments | RON 1.1M | RON 809.6K |
| Proceeds From Current Borrowings | RON 2.3M | RON 13.3M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | RON 7.2M | RON 714.8K |
| Profit Loss From Continuing Operations | RON 11.6M | RON 4.6M |
| Property Plant and Equipment Revaluation Surplus | RON 5.6M | RON 10.2M |
| Purchase of Other Longterm Assets Classified As Investing Activities | RON 0 | RON 33.6K |
| Repayments of Current Borrowings | RON 13.2M | RON 10.9M |
| Reserve of Exchange Differences On Translation | -RON 2.8K | RON 152.9K |
| Reserve of Gains and Losses From Investments In Equity Instruments | -RON 51.1K | -RON 36.9K |
| Retained Earnings | RON 56.7M | RON 49.3M |
| Revaluation Surplus | RON 19.0M | RON 21.7M |
| Revenue and Operating Income | RON 890.3M | RON 810.9M |
| Share Premium | RON 2.0M | RON 2.0M |
| Tax Expense Relating To Profit Loss From Ordinary Activities of Discontinued Operations | RON 3.5M | RON 2.1M |
| Trade and Other Payables | RON 297.5M | RON 289.1M |
| Trade and Other Receivables | RON 223.2M | RON 219.5M |
| Treasury Shares | RON 133.5K | RON 147.6K |
Methodology
Every line item above is a fact tagged in ROPHARMA SA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (RON), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.